Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Bennett

Showing results (71-80 of 331) with videos related to

Pageof 34
Sort By:
Cancer Journal (Sudbury, Mass.)|September 26, 2025
National Stockpiling of Pediatric Cancer Medications in the United States: An Alternative Approach to Hospital-Based Storage for Essential Oncology DrugsMaxwell L Izen, Mia Lynch, Charles L Bennett
Social Work in Public Health|June 12, 2009
Partnering to promote equality in cancer careMelissa A Simon, Xinqi Dong, Charles L Bennett
Archives of Internal Medicine|August 11, 2010
Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer"Richard J Ablin, Oliver Sartor, Charles L Bennett
Urology|September 25, 2017
Editorial CommentZaina P Qureshi, Oliver Sartor, Charles L Bennett
Pediatrics|June 1, 2016
FDA Approval of Extended-Release Oxycodone for Children With Severe PainY Tony Yang, Brian Chen, Charles L Bennett
The American Journal of Managed Care|February 22, 2023
Humira: the first $20 billion drugJason B Gibbons, Micaela Laber, Charles L Bennett
Urology|May 22, 2012
Editorial commentSandip M Prasad, Thomas E Keane, Charles L Bennett
Urology|May 22, 2016
Editorial CommentCharles L Bennett, Sandip M Prasad, William A Kennedy
JAMA Oncology|July 17, 2015
Population-Based Assessment of Determining Treatments for Prostate CancerSandip M Prasad, A Oliver Sartor, Charles L Bennett
Cancer Treatment and Research|November 30, 2022
Biosimilar Epoetin in the United States: A View from the Southern Network on Adverse ReactionsSumimasa Nagai, Bartlett Witherspoon, Chadi Nabhan, et al.
Pageof 34

Showing results (71-80 of 331) with videos related to

Sort By:
Pageof 34
Cancer Journal (Sudbury, Mass.)|September 26, 2025
National Stockpiling of Pediatric Cancer Medications in the United States: An Alternative Approach to Hospital-Based Storage for Essential Oncology DrugsMaxwell L Izen, Mia Lynch, Charles L Bennett
Social Work in Public Health|June 12, 2009
Partnering to promote equality in cancer careMelissa A Simon, Xinqi Dong, Charles L Bennett
Archives of Internal Medicine|August 11, 2010
Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer"Richard J Ablin, Oliver Sartor, Charles L Bennett
Urology|September 25, 2017
Editorial CommentZaina P Qureshi, Oliver Sartor, Charles L Bennett
Pediatrics|June 1, 2016
FDA Approval of Extended-Release Oxycodone for Children With Severe PainY Tony Yang, Brian Chen, Charles L Bennett
The American Journal of Managed Care|February 22, 2023
Humira: the first $20 billion drugJason B Gibbons, Micaela Laber, Charles L Bennett
Urology|May 22, 2012
Editorial commentSandip M Prasad, Thomas E Keane, Charles L Bennett
Urology|May 22, 2016
Editorial CommentCharles L Bennett, Sandip M Prasad, William A Kennedy
JAMA Oncology|July 17, 2015
Population-Based Assessment of Determining Treatments for Prostate CancerSandip M Prasad, A Oliver Sartor, Charles L Bennett
Cancer Treatment and Research|November 30, 2022
Biosimilar Epoetin in the United States: A View from the Southern Network on Adverse ReactionsSumimasa Nagai, Bartlett Witherspoon, Chadi Nabhan, et al.
Pageof 34